Back to today’s briefing

Story perspectives

Oura Health Targets September 2026 IPO Valued Above $16B

8/25/2026

50 6 Full Breakdown

Summary

Story summary

Oura Health plans a U.S. IPO in September 2026 valuing the company above $16 billion.
The offering aims to raise up to $3 billion, with Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., and Jefferies leading underwriting.
A class-action suit filed August 20 alleges Oura misled consumers about sleep-tracking accuracy.
Existing investors such as Fidelity, ICONIQ, and Temasek may sell a significant share of the new stock.

History

Historical Context

Fitbit, founded by James Park and Eric Friedman in San Francisco in March 2007, evolved from a niche tracker to a major consumer-health brand. In June 2015 it listed on the NYSE, raising $732 million and valuing the company at $4.1 billion, with Morgan Stanley and Goldman Sachs underwriting. The IPO’s volatility now frames later wearables such as Oura’s 2026 debut and Google’s 2021 acquisition of Fitbit.

1 of 2

Story summary

Oura Health plans a U.S. IPO in September 2026 valuing the company above $16 billion.
The offering aims to raise up to $3 billion, with Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., and Jefferies leading underwriting.
A class-action suit filed August 20 alleges Oura misled consumers about sleep-tracking accuracy.
Existing investors such as Fidelity, ICONIQ, and Temasek may sell a significant share of the new stock.

1 / 2